PARK CITY, Utah, Jan. 29, 2015 /PRNewswire/ -- Nutraceutical
International Corporation (NASDAQ: NUTR) today reported
results for the fiscal 2015 first quarter ended December 31, 2014. Net sales for the fiscal
2015 first quarter were $53.0 million
compared to $51.6 million for the
same quarter of fiscal 2014. For the first quarter of fiscal
2015, net income was $3.4 million, or
$0.35 diluted earnings per share,
compared to net income of $4.1
million, or $0.42 diluted
earnings per share, for the same quarter of fiscal 2014.
Operating cash flow for the fiscal 2015 first quarter was
$3.0 million compared to $5.5 million for the same period of fiscal
2014. The fiscal 2015 first quarter operating cash flow,
combined with existing cash, was primarily used to invest
$2.6 million in purchases of
property, plant and equipment, $1.1
million in purchases of common stock for treasury and to
repay net borrowings of $1.0 million
on the Company's revolving credit facility.
Bill Gay, chairman and chief
executive officer, commented, "Our fiscal 2015 first quarter net
sales growth of 2.9% was primarily the result of fiscal 2014
acquisitions. Non-acquisition net sales during the quarter were
down slightly as a result of increased product out-of-stocks and
some health food store market softness. Reducing
out-of-stocks is a key priority. We continue to anticipate
operational synergies and further net sales growth from the fiscal
2014 acquisitions in the later part of 2015."
Mr. Gay stated, "Adjusted EBITDA remained strong, although it
decreased from the comparable fiscal 2014 quarter as a result of
lower gross margins and increases in marketing, selling and
distribution expenses, which came principally from the integration
of fiscal 2014 acquisitions. The decrease in fiscal 2015
quarterly net income was primarily a result of increased
amortization and depreciation expense relating to acquisitions and
capital investments in equipment."
Mr. Gay continued, "Management is confident that its ongoing
focus to integrate the fiscal 2014 acquisitions, decrease
out-of-stocks, reduce inventory, consolidate labor, redirect
promotional efforts, introduce strong new products and more
effectively utilize its sales force will provide a foundation for
desired cost synergies and sustainable growth over the coming
years. Acquisitions are critically important to our growth and this
will not change. Integration of acquisitions has been a core
competency over many years, although the fiscal 2014 acquisitions
have been particularly challenging. Management appreciates the
ongoing strategic long-term growth perspective our customers,
employees and stockholders provide as we continue to enhance and
grow our business."
ABOUT NUTRACEUTICAL
We are an integrated manufacturer, marketer, distributor and
retailer of branded nutritional supplements and other natural
products sold primarily to and through domestic health and natural
food stores. Internationally, we market and distribute
branded nutritional supplements and other natural products to and
through health and natural product distributors and
retailers. Our core business strategy is to acquire,
integrate and operate businesses in the natural products industry
that manufacture, market and distribute branded nutritional
supplements. We believe that the consolidation and
integration of these acquired businesses provides ongoing financial
synergies through increased scale and market penetration, as well
as strengthened customer relationships.
We manufacture and sell nutritional supplements and other
natural products under numerous brands including Solaray®,
KAL®, Nature's Life®, LifeTime®, Natural
Balance®, NaturalCare®, Health from the Sun®,
Pioneer®, Nutra BioGenesis™, Life-flo®,
Organix South®, Heritage Store® and Monarch
Nutraceuticals™.
We own neighborhood natural food markets, which operate under
the trade names The Real Food Company™, Thom's Natural
Foods™ and Cornucopia Community Market™. We also
own health food stores, which operate under various trade names
including Fresh Vitamins™, Granola's™ and
Peachtree Natural Foods®.
We manufacture and/or distribute one of the broadest branded
product lines in the industry with over 8,000 SKUs, including
approximately 800 SKUs exclusively sold internationally. We
believe that as a result of our emphasis on innovation, quality,
loyalty, education and customer service, our brands are widely
recognized in health and natural food stores and among their
customers.
This Press Release contains forward-looking statements within
the meaning of the Private Securities Litigation Reform Act of 1995
with respect to our financial condition, results of operations and
business. These forward-looking statements can be identified
by the use of terms such as "believe," "expects," "plan," "intend,"
"may," "will," "should," "can," or "anticipates," or the negative
thereof, or variations thereon, or comparable terminology, or by
discussions of strategy. These statements involve known and unknown
risks, uncertainties and other factors that may cause industry
trends or our actual results to be materially different from any
future results expressed or implied by these statements.
Important factors that may cause our results to differ from these
forward-looking statements include, but are not limited to: (i)
changes in or new government regulations or increased enforcement
of the same, (ii) unavailability of desirable acquisitions,
inability to complete them or inability to integrate them,
(iii) increased costs, including from increased raw material or
energy prices, (iv) changes in general worldwide economic or
political conditions, (v) adverse publicity or negative consumer
perception regarding nutritional supplements, (vi) issues with
obtaining raw materials of adequate quality or quantity, (vii)
litigation and claims, including product liability, intellectual
property and other types, (viii) disruptions from or
following acquisitions including the loss of customers, (ix)
increased competition, (x) slow or negative growth in the
nutritional supplement industry or the healthy foods channel, (xi)
the loss of key personnel or the inability to manage our operations
efficiently, (xii) problems with information management systems,
manufacturing efficiencies and operations, (xiii) insurance
coverage issues, (xiv) the volatility of the stock market generally
and of our stock specifically, (xv) increases in the cost of
borrowings or unavailability of additional debt or equity capital,
or both, or fluctuations in foreign currencies, and (xvi)
interruption of business or negative impact on sales and earnings
due to acts of God, acts of war, terrorism, bio-terrorism, civil
unrest and other factors outside of our control. Copies of
our SEC reports are available upon request from our investor
relations department or may be obtained at the SEC's website
(www.sec.gov).
NUTRACEUTICAL
INTERNATIONAL CORPORATION
|
CONDENSED
CONSOLIDATED BALANCE SHEETS
|
(unaudited;
dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
December
31,
|
|
September
30,
|
|
|
|
2014
|
|
2014
|
Assets
|
|
|
|
|
Current assets,
net
|
$
80,665
|
|
$
83,850
|
Property, plant and
equipment, net
|
79,870
|
|
79,244
|
Goodwill
|
23,622
|
|
23,622
|
Other non-current assets,
net
|
27,743
|
|
28,062
|
|
|
|
$ 211,900
|
|
$ 214,778
|
|
|
|
|
|
|
Liabilities and
Stockholders' Equity
|
|
|
|
Current
liabilities
|
$
17,393
|
|
$
21,709
|
Long-term
liabilities
|
42,310
|
|
43,456
|
Stockholders'
equity
|
152,197
|
|
149,613
|
|
|
|
$ 211,900
|
|
$ 214,778
|
NUTRACEUTICAL
INTERNATIONAL CORPORATION
|
CONDENSED
CONSOLIDATED STATEMENTS OF OPERATIONS
|
(unaudited;
dollars in thousands, except per share data)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
December 31,
|
|
|
|
|
2014
|
|
2013
|
|
Net sales
|
$
53,044
|
|
$
51,550
|
|
Cost of
sales
|
27,189
|
|
25,488
|
|
|
|
Gross
profit
|
25,855
|
|
26,062
|
|
Operating
expenses
|
|
|
|
|
|
|
Selling, general and
administrative
|
19,554
|
|
18,581
|
|
|
|
Amortization of
intangible assets
|
732
|
|
584
|
|
Income from
operations
|
5,569
|
|
6,897
|
|
Interest and other
expense, net
|
297
|
|
318
|
|
Income before
provision for income taxes
|
5,272
|
|
6,579
|
|
Provision for income
taxes
|
1,921
|
|
2,444
|
|
|
|
|
|
|
|
|
Net income
|
$
3,351
|
|
$
4,135
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income per common
share
|
|
|
|
|
|
|
Basic
|
$
0.35
|
|
$
0.42
|
|
|
|
Diluted
|
0.35
|
|
0.42
|
|
|
|
|
|
|
|
|
Weighted average
common shares outstanding
|
|
|
|
|
|
|
Basic
|
9,653,113
|
|
9,837,631
|
|
|
|
Diluted
|
9,660,007
|
|
9,847,659
|
|
NUTRACEUTICAL
INTERNATIONAL CORPORATION
|
ADJUSTED EBITDA
SCHEDULE
|
(unaudited;
dollars in thousands)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended
December 31,
|
|
|
|
2014
|
|
2013
|
|
|
|
|
|
|
Net income
|
$ 3,351
|
|
$
4,135
|
Provision for income
taxes
|
1,921
|
|
2,444
|
Interest and other
expense, net (1)
|
297
|
|
318
|
Depreciation and
amortization
|
3,239
|
|
2,638
|
|
|
|
|
|
|
Adjusted
EBITDA
|
$
8,808
|
|
$
9,535
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1)
|
Includes amortization
of deferred financing fees.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP Financial
Measures
|
|
|
|
Adjusted EBITDA (a non-GAAP
measure) is defined in our performance measures as earnings before
net interest and other expense, taxes, depreciation, amortization
and goodwill and intangible asset impairments. We believe
that Adjusted EBITDA provides useful additional information to
analysts, creditors, investment bankers and management regarding
operating performance and debt covenant compliance. Adjusted
EBITDA has some inherent limitations in measuring operating
performance due to the exclusion of certain financial elements such
as depreciation and amortization and is not necessarily comparable
to other similarly-titled captions of other companies due to
potential inconsistencies in the method of calculation.
Furthermore, Adjusted EBITDA is not intended to be an alternative
to net income in determining our operating performance in
accordance with generally accepted accounting
principles.
|
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nutraceutical-reports-fiscal-2015-q1-results-300027557.html
SOURCE Nutraceutical International Corporation